The government has suggested weight-loss drugs could boost the economy by helping obese people in England get back to work.

The upcoming approval for the NHS to use another injection, called Mounjaro, dubbed by some as the King Kong of weight loss ...

New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health ...

Providing coverage for weight-loss drugs such as Wegovy and Ozempic is forcing employers to make some critical decisions.

or participation in a weight-loss program. The class of drugs that includes Wegovy, Ozempic and Mounjaro is known as Semaglutide (within the GLP-1 classification). The class originally was ...

I've watched several people, including myself, go on weight loss adventures, whether through rigid diets, intense gym ...

You’ve probably heard of the semaglutide brand names Ozempic®, Wegovy, and Rybelsus. You may have even heard about affordable options like compounded semaglutide.

If your insurance covers weight loss drugs like Ozempic and Wegovy, you'll pay an average of $321 per month. Though if your plan has good coverage, you could pay as little as $25 per month. Blue Cross ...

Hoping your company will begin paying for anti-obesity medications like Wegovy? You may be in luck. A growing number of ...

Novo Nordisk, the pharmaceutical company behind the world’s most popular weight-loss injections, is expanding its global ...

The latest plan to tackle obesity in the UK could also help to get people back into work, but what are the risks?

Under the plan revealed by health secretary ... and will take place in Greater Manchester. Weight-loss jab Semaglutide, called Wegovy, was approved for use on the NHS in 2023.